Impact of PM2.5 Exposure on Cardiovascular Diseases [IPEC Study]: An Updated Umbrella Review of Systematic Reviews and Meta-Analyses

Sethi, Yashendra ORCID logoORCID: https://orcid.org/0000-0003-0345-3876, Mehta, Sameer, Padda, Inderbir, Marlecha, Pranay ORCID logoORCID: https://orcid.org/0000-0003-1399-9952 and Moinuddin, Arsalan ORCID logoORCID: https://orcid.org/0000-0002-4242-1714 (2026) Impact of PM2.5 Exposure on Cardiovascular Diseases [IPEC Study]: An Updated Umbrella Review of Systematic Reviews and Meta-Analyses. European Journal of Preventive Cardiology. doi:10.1093/eurjpc/zwag005 (In Press)

Full text not available from this repository.

Abstract

Background Fine particulate matter (PM2.5) is a well-recognized environmental pollutant increasingly implicated in the pathogenesis of cardiovascular disease (CVD). Whilst numerous studies have established its deleterious effects, incongruencies in the magnitude, dose-response gradients, and modifying factors across systematic reviews (SRs) and MAs (MAs) have limited translational clarity. Methods Per the PRISMA guidelines, we conducted an umbrella review of SRs and MAs examining the association between PM2.5 exposure and cardiovascular morbidity, mortality, or intermediate biomarkers in human populations. Searches were performed across PubMed, Scopus, Embase, Web of Science, Cochrane Library, and Google Scholar up to June 2025. The methodological quality of included reviews was appraised using AMSTAR 2 and ROBIS. Results Thirty-eight SRs and MAs met eligibility criteria, encompassing data from diverse geographic regions and demographic settings. Cumulative evidence demonstrates a robust association between both short- and long-term PM2.5 exposure and elevated cardiovascular risk, including myocardial infarction (RR: 1.02, 95% CI: 1.01–1.03), stroke (RR: 1.011, 95% CI: 1.010–1.012), heart failure (RR: 1.018, 95% CI: 1.011–1.025), arrhythmia (RR: 1.015, 95% CI: 1.006–1.024), and other cardiovascular mortality. Several reviews identified dose-dependent relationships, with increased risk observable even at PM2.5 concentrations below current WHO standards (5 µg/m³ annual mean; 15 µg/m³ 24-hour mean), U.S. national air quality standards (12 µg/m³ annual mean; 35 µg/m³ 24-hour mean), and Indian national air quality standards (40 µg/m³ annual mean; 60 µg/m³ 24-hour mean) have also been associated with increased cardiovascular risk. Subgroup analyses highlighted increased susceptibility among older adults, individuals with pre-existing CVD, and populations in low- and middle-income countries. Whilst most reviews were rated as moderate-to-high quality, methodological heterogeneity in exposure assessment and under-representation of data from South Asia and sub-Saharan Africa remain key limitations. Conclusions This umbrella review consolidates high-level evidence linking PM2.5 exposure to a broad spectrum of adverse cardiovascular outcomes. The findings underscore the urgent need to tighten global air quality regulations, prioritize vulnerable populations, and advance mechanistic and regional research to inform tailored policy interventions.

Item Type: Article
Article Type: Article
Subjects: R Medicine > R Medicine (General)
R Medicine > RA Public aspects of medicine
Divisions: Schools and Research Institutes > School of Education, Health and Sciences
Depositing User: Charlotte Crutchlow
Date Deposited: 14 Jan 2026 10:40
Last Modified: 14 Jan 2026 10:40
URI: https://eprints.glos.ac.uk/id/eprint/15742

University Staff: Request a correction | Repository Editors: Update this record

University Of Gloucestershire

Bookmark and Share

Find Us On Social Media:

Social Media Icons Facebook Twitter YouTube Pinterest Linkedin

Other University Web Sites

University of Gloucestershire, The Park, Cheltenham, Gloucestershire, GL50 2RH. Telephone +44 (0)844 8010001.